Literature DB >> 19924391

[Orthopedic made-to-measure shoes for diabetics. Long-term 5-year outcome].

U Illgner1, J Wühr, M Rümmler, B Drerup, H H Wetz.   

Abstract

For patients with diabetes mellitus and diabetic foot syndrome customized orthopedic shoes represent the most effective treatment to avoid foot ulceration and amputation. A total of 53 patients suffering from diabetes and treated with customized orthopedic shoes for more than 5 years were included in the study. Of the patients 91% had peripheral artery occlusion disease, polyneuropathy and diabetic neuropathic osteoarthropathy (DNOAP) and in nearly 25% amputation of one limb had already been carried out. The incidence of ulcers over a time period of 5 years was assessed from the patient records and questioning the patients. Questions on the duration of wearing orthopedic shoes, the durability of the shoes and resulting pain were also included. All patients except for one had problems walking on uneven surfaces. Of the patients 89% claimed to have used their shoes always or nearly always and 25% of the shoes had to be replaced after 1 year. The incidence of ulcers was 38% after 5 years. Treatment with customized orthopedic shoes is an effective method to prevent ulcers and amputation. To be successful it is necessary to control that the shoes are made correctly. Not all shoes last as long as 2 years.

Entities:  

Mesh:

Year:  2009        PMID: 19924391     DOI: 10.1007/s00132-009-1507-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  14 in total

Review 1.  Who is at risk for diabetic foot ulceration?

Authors:  D G Armstrong; L A Lavery; L B Harkless
Journal:  Clin Podiatr Med Surg       Date:  1998-01       Impact factor: 1.231

2.  Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.

Authors:  E J Peters; L A Lavery
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

3.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; G E Reiber; E H Wagner
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

4.  New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up.

Authors:  E Faglia; F Favales; A Morabito
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

5.  Elevated peak plantar pressures in patients who have Charcot arthropathy.

Authors:  D G Armstrong; L A Lavery
Journal:  J Bone Joint Surg Am       Date:  1998-03       Impact factor: 5.284

6.  The epidemiology of foot lesions in diabetic patients aged 15-50 years.

Authors:  B Borssén; T Bergenheim; F Lithner
Journal:  Diabet Med       Date:  1990-06       Impact factor: 4.359

7.  The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study.

Authors:  M J Young; J L Breddy; A Veves; A J Boulton
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

8.  The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?

Authors:  M J McNeely; E J Boyko; J H Ahroni; V L Stensel; G E Reiber; D G Smith; R F Pecoraro
Journal:  Diabetes Care       Date:  1995-02       Impact factor: 19.112

9.  Footwear used by individuals with diabetes and a history of foot ulcer.

Authors:  Gayle E Reiber; Douglas G Smith; Carolyn M Wallace; Christy A Vath; Katrina Sullivan; Shane Hayes; Onchee Yu; Don Martin; Matthew Maciejewski
Journal:  J Rehabil Res Dev       Date:  2002 Sep-Oct

10.  Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers.

Authors:  J Apelqvist; J Castenfors; J Larsson; A Stenström; C D Agardh
Journal:  Diabet Med       Date:  1989-08       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.